Furthermore, in xenograft models in vivo, DuoHexaBody-CD37 induced significant inhibition of tumor growth in a CLL CDX model, two NHL CDX models and six out of nine NHL PDX models. This evidence concerns the gene CD37 and B-cell chronic lymphocytic leukemia.